Show Article with tag "biotech & biomedical"

Neuren’s US Partner Acadia Reports Sales Growth and Future Prospects Neuren Pharmaceuticals (ASX:NEU) has seen positive developments in its partnership with Acadia Pharmaceuticals, which reported a 14% increase in quarterly net sales. The Nasdaq-listed company recorded sales of US$96.1 million for the quarter, showing continued growth for the third consecutive quarter. This success is attributed […]

Nanosonics Secures Second FDA Approval, Boosting Market Potential Nanosonics has achieved a significant milestone with its second Food and Drug Administration (FDA) approval this year, marking another success in its journey of innovation. The company recently received approval for the next-generation versions of its medical probe steriliser, Trophon. This development is expected to enable the […]